Intralesional sodium thiosulfate treatment of calcinosis cutis in pseudopseudohypoparathyroidism.
calcinosis
pseudohypoparathyroidism
pseudopseudohypoparathyroidism
sodium thiosulfate
therapeutics
Journal
Pediatric dermatology
ISSN: 1525-1470
Titre abrégé: Pediatr Dermatol
Pays: United States
ID NLM: 8406799
Informations de publication
Date de publication:
May 2022
May 2022
Historique:
revised:
22
01
2022
received:
30
09
2021
accepted:
07
02
2022
pubmed:
27
2
2022
medline:
12
7
2022
entrez:
26
2
2022
Statut:
ppublish
Résumé
Pseudopseudohypoparathyroidism is an imprinted GNAS spectrum disorder that induces the phenotype of Albright's hereditary osteodystrophy. This phenotype often involves the formation of calcinosis cutis: firm, painful cutaneous eruptions, which are classically difficult to treat. Intralesional sodium thiosulfate has been reported successfully in various cases of calcinosis cutis; however, these reports describe patients with autoimmune or idiopathic calcinosis. This case details the clinical improvement and resolution of calcinosis cutis lesions utilizing intralesional sodium thiosulfate in an adolescent patient with pseudopseudohypoparathyroidism.
Substances chimiques
Thiosulfates
0
sodium thiosulfate
HX1032V43M
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
425-428Informations de copyright
© 2022 Wiley Periodicals LLC.
Références
Niebel D, Poortinga S, Wenzel J. Osteoma cutis and calcinosis cutis: "similar but different". J Clin Aesthet Dermatol. 2020;13(11):28-31.
Schneller-Pavelescu L, Vergara de Caso E, Pastor-Tomás N, Gutiérrez Agulló M, Ruiz Pérez L, Betlloch MI. Presentation of pseudohypoparathyroidism and pseudopseudohypoparathyroidism with skin lesions: case reports and review. Pediatr Dermatol. 2019;36(3):355-359.
Wilson LC, Hall CM. Albright's hereditary osteodystrophy and pseudohypoparathyroidism. Semin Musculoskelet Radiol. 2002;6(4):273-283.
Valenzuela A, Chung L. Calcinosis: pathophysiology and management. Curr Opin Rheumatol. 2015;27(6):542-548.
Traineau H, Aggarwal R, Monfort JB, et al. Treatment of calcinosis cutis in systemic sclerosis and dermatomyositis: a review of the literature. J Am Acad Dermatol. 2020;82(2):317-325.
López-Sundh AE, Quintana-Sancho A, Durán-Vian C, et al. Clinical and ultrasound response to intralesional sodium thiosulfate for the treatment of calcinosis cutis in the setting of systemic sclerosis. A case-based review. Clin Rheumatol. 2021;40(7):2985-2989.
Howard RM, Smith GP. Treatment of calcinosis cutis with sodium thiosulfate therapy. J Am Acad Dermatol. 2020;83(5):1518-1520.
Strazzula L, Nigwekar SU, Steele D, et al. Intralesional sodium thiosulfate for the treatment of calciphylaxis. JAMA Dermatol. 2013;149(8):946-949.
Darrieurtort-Laffite C, Bertrand-Vasseur A, Garraud T, Planche L, Le Goff B. Tolerance and effect of sodium thiosulfate in calcific tendinitis of the rotator cuff. Clin Rheumatol. 2020;39(2):561-569.
Robinson DM. Commentary on the use of intralesional sodium thiosulfate to dissolve facial nodules from calcium hydroxylapatite. Dermatol Surg. 2020;46(10):1368-1370.
Gunasekera NS, Maniar LEG, Lezcano C, Laga AC, Merola JF. Intralesional sodium thiosulfate treatment for calcinosis cutis in the setting of lupus panniculitis. JAMA Dermatol. 2017;153(9):944-945.
Winter AR, Klager S, Truong R, Foley A, Sami N, Weinstein D. Efficacy of intralesional sodium thiosulfate for the treatment of dystrophic calcinosis cutis: A double-blind, placebo-controlled pilot study. JAAD Int. 2020;1(2):114-120.
Schlund M, Depeyre A, Kohler F, Nicot R, Ferri J. Cranio-maxillofacial and dental findings in albright's hereditary osteodystrophy and pseudohypoparathyroidism. Cleft Palate Craniofac J. 2019;56(6):831-836.